This cross-sectional study examines postmarket safety actions for novel oncology drugs that received accelerated Food and Drug Administration (FDA) approval.

Despite the importance of postmarketing requirements (PMRs) following accelerated approval and well-recognized shortcomings in their rigor and timeliness,

President Donald Trump took his most extensive step yet toward overhauling the US legal migration system, with a pair of proclamations that explicitly favor the wealthiest of the world’s prospective e...

The FDA today announced a plan to p | The Food and Drug Administration today announced a plan to publicly release complete response letters at the same time they are issued to sponsoring companies, pa...

The state’s elimination of vaccine mandates is a courageous first step toward decluttering itself of any excess kids.

State efforts to protect access to shots are welcome, but they can’t compensate for others’ anti-science policies and a dysfunctional CDC.

International climate experts have extensively debunked the D.O.E.’s recent report, but will science win out?

Nearly 80% of neurologists prescribing MS drugs received at least one industry payment, with higher volume prescribers being more likely to receive payments. Physicians receiving payments were more li...

Data can easily be manipulated to show a causation that doesn’t exist.

With a new proposal, the Trump Administration, which has already laid waste to dozens of programs aimed at limiting climate change, has managed to outdo itself.

Trump pledged to root out "waste, fraud and abuse." Then a big contribution to his Super PAC came in.

Experts say the report being used to justify the mass rollback of climate regulations has many claims based on long-debunked research

Elevating contrarian views while burying the actual science

On March 15, President Donald Trump’s administration sent more than 230 Venezuelan immigrants to a maximum-security prison in El Salvador. Last week, the men were released as suddenly as they’d been t...

The company, owned by the world's wealthiest man, says it is a "small disadvantaged business"

This policy watch examines 988 on its third anniversary, drawing from the latest Lifeline data available through May 2025 and suicide death data from CDC WONDER for the period 2013 to 2023. 988 receiv...

Cuts to federal health-care spending make it harder for doctors to make the oldest promise in medicine: that we will do no harm.

Why the Medicaid work requirement is a terrible idea

Policy analysts expect millions of Americans to lose coverage because of cumbersome paper work, bureaucratic hurdles and noncompliance

Before the measles vaccine became widely available in the 1960s, nearly everyone in the United States contracted measles by the timethey were 15.

Instructions in preprints from 14 universities highlight controversy on AI in peer review

The administration's cuts to the Department of Health and Human Services are going to do irreparable harm to the nation’s health.

Medicine is now the nation’s largest employer, but its growth may be slowing.

A new ProPublica data analysis adds to the mounting evidence that abortion bans have made the common experience of first-trimester miscarriage far more dangerous.

Time to take a stand, again, against racism

The research on what smoke does to a body is just beginning.

GOP lawmakers want to nationalize Medicaid work requirements to offset Trump’s proposed tax cuts. Yet Georgia’s example shows that this could threaten health care for nearly 16 million Americans and…

One chart on the Big Ugly Bill

Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries at risk

New blood tests promise to detect malignancies before they’ve spread. But proving that these tests actually improve outcomes remains a stubborn challenge.

Trying to understand the planet and its politics on the longest day